Axim Biotechnologies Inc (AXIM)

[Devolution]

Three things:

Cancer was their main theme. Currently, the DED line is their near term money maker that will carry them into the future. Revenues from their cancer research are still years down the road.

This is not the "really big piece of negative news" that you may think it is. I mean, for Empowered maybe, but Immunopass is still the "First-in-Class" product hoping to help society get through this particular emergency crisis. In all truth, if AXIM put out a statement saying "this is no big deal", no one would believe it. There just isn't too much that can be said....just yet....but perhaps, if AXIM does switch manufacturers, then there will be something worth reporting.

The funding of AXIM will soon be via the DED line, if that hasn't started already. Keep in mind, Empowered is NOT the manufacturer of the DED test kits , so this recent bit of news in no way effects the DED line, and it is the revenues from the DED line that were deemed to carry AXIM forward into the future - regardless of the outcome of Immunopass.

REMEMBER from the last 10-K: The DED line revenues are believed to make AXIM profitable by the end of 2022.

There is still a hell of a lot of life left in this company.

This is just another hill in the rollercoaster ride.

Keep in mind:

The only ones most certainly to get hurt on a rollercoaster are the ones who try to get off before the ride gets to the end.